Bruno Bockorny

Beth Israel Deaconess Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Mariano Ponz-Sarvise

Universidad de Navarra

SPAIN

View details

Joseph Grossman

VP, Head of Exploratory Medicine

UNITED STATES

View details

Manuel Hidalgo

Weill Cornell Medical College

UNITED STATES

View details

John Clohessy

Assistant Professor

Harvard Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bruno Bockorny

Research Interests

Explore related searches

Contact this professor

Articles (11)

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer

First Results of Migoprotafib, a Potent and Highly Selective Src Homology-2 Domain–Containing Phosphatase 2 Inhibitor in Patients with Advanced Solid Tumors

A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer

A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer

A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer

Facts and Hopes in Immunotherapy of Pancreatic Cancer

Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer

Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

PDX-derived organoids model in vivo drug response and secrete biomarkers.

Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trial

Collaborators (4)

Mariano Ponz-Sarvise

Joseph Grossman

Manuel Hidalgo

John Clohessy

Make your next move.